Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added note that publications are automatically filled from PubMed and included Revision: v3.3.2. Removed the older text stating PubMed publications are automatically created by ClinicalTrials.gov and may not be about the study.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:22.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The funding-status notice about potential delays due to a lapse in government funding has been removed. All study details and eligibility information remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:00:50.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A new publication entry was added to Publications: Chahla B, Stephen B, Song J, Balderrama-Brondani V, Yaylaci F, Campbell MT, Naing A, Habra MA; Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma, J Immunother Precis Oncol. 2025 Oct 6;8(4):242-248; doi: 10.36401/JIPO-25-6; eCollection 2025 Nov.
    Difference
    0.4%
    Check dated 2025-11-03T21:09:43.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:34:08.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.0%
    Check dated 2025-09-29T03:05:32.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:14:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.